Back
Zentalis Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
ZNTL
Zentalis Pharmaceuticals
Last Price:
$1.39
Seasonality Move:
-6.64%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZNTL is experiencing selling pressure, which indicates risk of future bearish movement.
Zentalis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.37 | Buy |
| 20-day SMA: | 1.3 | Buy |
| 50-day SMA: | 1.32 | Buy |
| 200-day SMA: | 2.21 | Sell |
| 8-day EMA: | 1.24 | Buy |
| 20-day EMA: | 0.81 | Buy |
| 50-day EMA: | 0.41 | Buy |
| 200-day EMA: | 0.12 | Buy |
Zentalis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 55.69 | Buy |
| Chaikin Money Flow: | -361244 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.24 - 1.42) | Buy |
| Bollinger Bands (100): | (1.19 - 1.73) | Sell |
Zentalis Pharmaceuticals Technical Analysis
| Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zentalis Pharmaceuticals Stock
Is Zentalis Pharmaceuticals Stock a Buy?
-
Zentalis Pharmaceuticals share price is 1.41 while ZNTL 8-day simple moving average is 1.37, which is a Buy signal.
-
The stock price of ZNTL is 1.41 while Zentalis Pharmaceuticals 20-day SMA is 1.30, which makes it a Buy.
-
Zentalis Pharmaceuticals 50-day simple moving average is 1.32 while ZNTL share price is 1.41, making it a Buy technically.
-
ZNTL stock price is 1.41 and Zentalis Pharmaceuticals 200-day simple moving average is 2.21, creating a Sell signal.
ZNTL Technical Analysis vs Fundamental Analysis
Sell
23
Zentalis Pharmaceuticals (ZNTL)
is a Sell
Is Zentalis Pharmaceuticals a Buy or a Sell?
-
Zentalis Pharmaceuticals stock is rated a SellThe current Zentalis Pharmaceuticals [ZNTL] share price is $1.41. The Score for ZNTL is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Zentalis Pharmaceuticals Stock Info
Market Cap:
101.5M
Price in USD:
1.41
Share Volume:
412.9K
Zentalis Pharmaceuticals 52-Week Range
52-Week High:
5.44
52-Week Low:
1.01
Sell
23
Zentalis Pharmaceuticals (ZNTL)
is a Sell
Zentalis Pharmaceuticals Share Price Forecast
-
What is the Zentalis Pharmaceuticals stock price today?The Zentalis Pharmaceuticals stock price is 1.41 USD today.
-
Will ZNTL stock go up or go down?Zentalis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Zentalis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zentalis Pharmaceuticals is overvalued.
Is Zentalis Pharmaceuticals Stock a Buy?
-
Zentalis Pharmaceuticals share price is 1.41 while ZNTL 8-day exponential moving average is 1.24, which is a Buy signal.
-
The stock price of ZNTL is 1.41 while Zentalis Pharmaceuticals 20-day EMA is 0.81, which makes it a Buy.
-
Zentalis Pharmaceuticals 50-day exponential moving average is 0.41 while ZNTL share price is 1.41, making it a Buy technically.
-
ZNTL stock price is 1.41 and Zentalis Pharmaceuticals 200-day simple moving average is 0.12, creating a Buy signal.
Fundamental Analysis of Zentalis Pharmaceuticals
Is Zentalis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.19 per share, and an increase next year of $0.06 per share.
Technical Analysis of Zentalis Pharmaceuticals
Should I short Zentalis Pharmaceuticals stock?
-
ZNTL Moving Average Covergence Divergence (MACD) indicator is 0.39, suggesting Zentalis Pharmaceuticals is a Buy
-
Zentalis Pharmaceuticals Relative Strength Index (RSI) is 55.69, which suggest Zentalis Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Zentalis Pharmaceuticals is (1.24 - 1.42), which suggest Zentalis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Zentalis Pharmaceuticals is (1.19 - 1.73), which suggest Zentalis Pharmaceuticals is a Sell
* Zentalis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.